Anamika Das¹*, Pinaki Chakravarty² and Kushal Deori³

¹Post Graduate Trainee, Department of Pharmacology, Tezpur Medical College and Hospital, Tezpur, Assam, India
²Professor and HOD, Department of Pharmacology, Tezpur Medical College and Hospital, Tezpur, Assam, India
³Assistant Professor, Department of Pharmacology, Tezpur Medical College and Hospital, Tezpur, Assam, India

*Corresponding Author: Anamika Das, Post Graduate Trainee, Department of Pharmacology, Tezpur Medical College and Hospital, Tezpur, Assam, India.

Received: June 17, 2024; Published: July 24, 2024

Abstract

Background: Alcoholic Liver Disease (ALD) encompasses a range of conditions such as cirrhosis, hepatocellular carcinoma, steatohepatitis and fatty liver that result from excessive alcohol consumption. A period of alcohol abstinence combined with nutritional supplements is beneficial for liver health. Indicators for WHO core prescription are a valuable resource for assessing the appropriate use of medications in patients with alcoholic liver disease.

Aim and Objective: To use WHO core prescription indicators to examine the medicine prescribing trend for alcoholic liver disease.

Methodology: During this five months study from May 2023 to September 2023, in the Tezpur Medical College and Hospital, medical records were examined of patients who were diagnosed with ALD.

Results: A total of 110prescriptions are studied in which 776 number of drugs are prescribed, with an average of 7.05 medications per prescription. Out of 776, 553 number of drugs i.e. 71.2% are written under generic names and 69.1% are from national lists of essential medicines. The most often prescribed medications (28.3%) are hepato-protective therapy. Patients with alcohol-related liver illness may frequently exhibit a variety of supplementary co-morbidities, including edema, hepatic encephalopathy, and upper gastrointestinal bleeding. Numerous additional drugs are also prescribed for the same reason.

Conclusion: Periodic study of the drug prescription pattern of medications using WHO core prescribing indicators is necessary to enhance physician’s prescribing practices, quality of health care and this study may further minimizes potential drug-drug and drug-alcohol interactions, and contribute to better health outcomes.

 Keywords: Alcoholic Liver Disease; Hepato-Protective Drug; WHO Core Prescribing Indicators

References

1. Walsh K. “Alcoholic liver disease”. Postgraduate Medical Journal895 (2000): 280-286.
2. Duggan AE and Duggan JM. “Alcoholic liver disease - assessment and management”. Australian Family Physician 8 (2011): 590-593.
3. Doll R., et al. “Mortality in relation to consumption of alcohol: 13 years’ observations on male British doctors”. BMJ 309 (1994): 911-918.
4. Jamdade VS., et al. “Prescription pattern of drugs and WHO prescribing indicators used in alcoholic liver disease patients in a tertiary care teaching hospital in Northeastern India”. International Journal of Pharma and Bio Sciences 4 (2015): 503-510.
5. Dutta S., et al. “Study of prescribing pattern in diabetes mellitus patients in a tertiary care teaching hospital at Dehradun, Uttarakhand”. International Journal of Medical Science and Public Health Research 3 (2014)1351-1354.
6. Zeebaish S., et al. “A prospective observational study on prescribing patterns of drugs used in alcoholic liver disease patients at tertiary care teaching hospital”. International Journal of Basic & Clinical Pharmacology 6 (2017): 1386-1392.
7. Raynard B., et al. “Risk factors of fibrosis in alcohol-induced liver disease”. Hepatology3 (2002): 635-638.
8. European Association for the Study of the Liver Clinical Practical Guideline, Adopted. April (2016): 13- 17.
9. Bruha R., et al. “Alcoholic liver disease”. World journal of Hepatology3 (2012): 81-90.
10. Desalegn AA. “Assessment of drug use pattern using WHO prescribing indicators at Hawassa University Teaching and Referral Hospital, south Ethiopia: a cross-sectional study”. BMC Health Services Research 13 (2013): 170.

Citation

Citation: Anamika Das., et al. “Study on Prescribing Pattern of Drugs in Patients with Alcoholic Liver Diseases in a Tertiary Care Hospital, Assam”.Acta Scientific Medical Sciences 8.8 (2024): 145-150.

Copyright

Copyright: © 2024 Anamika Das., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.